[go: up one dir, main page]

WO2024126876A3 - Antimicrobial compounds for oral care - Google Patents

Antimicrobial compounds for oral care Download PDF

Info

Publication number
WO2024126876A3
WO2024126876A3 PCT/EP2024/058509 EP2024058509W WO2024126876A3 WO 2024126876 A3 WO2024126876 A3 WO 2024126876A3 EP 2024058509 W EP2024058509 W EP 2024058509W WO 2024126876 A3 WO2024126876 A3 WO 2024126876A3
Authority
WO
WIPO (PCT)
Prior art keywords
oral care
causing microorganisms
antimicrobial compounds
carbon atoms
hydrocarbon chains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/EP2024/058509
Other languages
French (fr)
Other versions
WO2024126876A2 (en
Inventor
Tom Fricke
Ute Back
Joerg Peter GROHMANN
Petra Riederle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clariant International Ltd
Original Assignee
Clariant International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clariant International Ltd filed Critical Clariant International Ltd
Publication of WO2024126876A2 publication Critical patent/WO2024126876A2/en
Publication of WO2024126876A3 publication Critical patent/WO2024126876A3/en
Anticipated expiration legal-status Critical
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the use of compound X selected from compounds of Formula (I) wherein R is selected from saturated hydrocarbon chains having to 23 carbon atoms, unsaturated hydrocarbon chains having 5 to 23 carbon atoms, and mixtures thereof, glyceryl ethers, sorbitan esters, and isosorbide esters as an antimicrobial agent against dental caries causing microorganisms, dental plaque causing microorganisms or gingivitis causing microorganisms.
PCT/EP2024/058509 2023-03-31 2024-03-28 Antimicrobial compounds for oral care Pending WO2024126876A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP23165977.2 2023-03-31
EP23165977 2023-03-31

Publications (2)

Publication Number Publication Date
WO2024126876A2 WO2024126876A2 (en) 2024-06-20
WO2024126876A3 true WO2024126876A3 (en) 2024-08-29

Family

ID=85800372

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2024/058509 Pending WO2024126876A2 (en) 2023-03-31 2024-03-28 Antimicrobial compounds for oral care

Country Status (1)

Country Link
WO (1) WO2024126876A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4548910A3 (en) * 2024-12-19 2025-07-16 Clariant International Ltd Compounds for use on mucosal tissue

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2807925A1 (en) * 2013-05-26 2014-12-03 Symrise AG Antimicrobial compositions
US20140369943A1 (en) * 2011-08-04 2014-12-18 Clariant International Ltd. Compositions comprising isosorbide monoesters and halogenated antimicrobial active compounds
WO2017106467A1 (en) * 2015-12-15 2017-06-22 Gontarz John A Oral care formulation and method for the removal of tartar and plaque from teeth
WO2018002100A1 (en) * 2016-06-29 2018-01-04 Clariant International Ltd Composition for inhibiting micro-organisms
US20190358133A1 (en) * 2016-05-31 2019-11-28 Kao Corporation Oral Composition
WO2020079531A1 (en) * 2018-10-18 2020-04-23 3M Innovative Properties Company Acyl-n-methylglucamide containing oral care composition for treating caries by reducing lactic acid release in oral biofilms
US20210169766A1 (en) * 2017-12-01 2021-06-10 Roquette Freres Use of dianhydrohexitol in oral and dental care to reduce the development of bacterial strains
EP3995127A1 (en) * 2020-11-06 2022-05-11 Basf Se Solubilizer free from ethoxylated emulsifiers
WO2022248954A1 (en) * 2021-05-26 2022-12-01 3M Innovative Properties Company Dental composition comprising an isorbide component

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2224973B1 (en) 2007-11-29 2016-04-20 Inolex Investment Corporation Preservatives for cosmetic, toiletry and pharmaceutical compositions
CN115362141B (en) 2018-01-30 2025-02-07 伊诺莱克斯投资公司 Natural 1,2-alkanediol, composition containing natural 1,2-alkanediol and preparation process thereof

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140369943A1 (en) * 2011-08-04 2014-12-18 Clariant International Ltd. Compositions comprising isosorbide monoesters and halogenated antimicrobial active compounds
EP2807925A1 (en) * 2013-05-26 2014-12-03 Symrise AG Antimicrobial compositions
WO2017106467A1 (en) * 2015-12-15 2017-06-22 Gontarz John A Oral care formulation and method for the removal of tartar and plaque from teeth
US20190358133A1 (en) * 2016-05-31 2019-11-28 Kao Corporation Oral Composition
WO2018002100A1 (en) * 2016-06-29 2018-01-04 Clariant International Ltd Composition for inhibiting micro-organisms
US20210169766A1 (en) * 2017-12-01 2021-06-10 Roquette Freres Use of dianhydrohexitol in oral and dental care to reduce the development of bacterial strains
WO2020079531A1 (en) * 2018-10-18 2020-04-23 3M Innovative Properties Company Acyl-n-methylglucamide containing oral care composition for treating caries by reducing lactic acid release in oral biofilms
EP3995127A1 (en) * 2020-11-06 2022-05-11 Basf Se Solubilizer free from ethoxylated emulsifiers
WO2022248954A1 (en) * 2021-05-26 2022-12-01 3M Innovative Properties Company Dental composition comprising an isorbide component

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
FREDERIC PILZ: "Sorbitan Caprylate - A new Preservative for Formulations", SOFW-JOURNAL, 1 August 2012 (2012-08-01), pages 32 - 35, XP055076138, Retrieved from the Internet <URL:http://www.essentialingredients.com/pdf/PreservationwithSorbitanCaprylate.pdf> [retrieved on 20130822] *
HAYES M L: "The effects of fatty acids and their monoesters on the metabolic activity of dental plaque", JOURNAL OF DENTAL RESEARCH, INTERNATIONAL ASSOCIATION FOR DENTAL RESEARCH, US, vol. 63, no. 1, 1 January 1984 (1984-01-01), pages 2 - 5, XP002389795, ISSN: 0022-0345 *

Also Published As

Publication number Publication date
WO2024126876A2 (en) 2024-06-20

Similar Documents

Publication Publication Date Title
IL160304A (en) Compounds and composition for activating peroxisome proliferators-responsive receptor ??
WO2024126876A3 (en) Antimicrobial compounds for oral care
DE60102171D1 (en) Ketolidantibiotika
WO2003049676A3 (en) Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the teatment of cancer
ATE386523T1 (en) SYNERGISTIC PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OR PROPHYLAXIS OF DIABETES
EP1147772A4 (en) Medicinal compositions for treatment of atrial fibrillation
CN111417438A (en) Use of dianhydrohexitol in oral hygiene for reducing the growth of bacterial strains
MX2024002674A (en) Thiadiazolone derivatives useful as ampk activator.
WO1992018091A1 (en) Antimicrobial oral compositions
PT1167376E (en) MACROLIDOS ANTIBIOTICS
AU2001256727A1 (en) Preventive or therapeutic drugs for cancers containing cyanidin compounds as theactive ingredient
ATE321550T1 (en) MEDICAL COMPOSITIONS FOR IMMEDIATE RELEASE FOR ORAL USE
WO2023247803A3 (en) Antimicrobial combinations
TW200724131A (en) Antibacterial 5,5&#39;-disubstituted 3,3&#39;-dialkoxy-2,2&#39;-dihydroxy-1,1&#39;-biphenyl compounds and related methods
WO2006120432A1 (en) Formulation to prevent plaque formation
ATE325109T1 (en) BENZOFURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
EP4552638A3 (en) Tofa analogs, sebum reduction compositions containing such analogs and cosmetic and/or therapeutic use of such analogs as a potent principle of sebum reduction or prevention
EP4548910A3 (en) Compounds for use on mucosal tissue
BRPI0414102A (en) compound use and composition
TW200508208A (en) Novel compound of 6-methyl-3-phenethyl-3,4-dihydro-1H-quinazoline-2-thione, its preparation and a depigmentation composition containing the same as an effective component
NO20005551L (en) 2 &#34;-deoksyhygromycinderivater
WO2024069021A3 (en) Compounds for use as wetting agents and/or dispersing agents
EP1288280A3 (en) Use of tertiary alcohols or esters as perfuming ingredients
EP4424298A3 (en) Antimicrobial compositions
TW200640464A (en) Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 202527065189

Country of ref document: IN

WWP Wipo information: published in national office

Ref document number: 202527065189

Country of ref document: IN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24716166

Country of ref document: EP

Kind code of ref document: A2

REG Reference to national code

Ref country code: BR

Ref legal event code: B01A

Ref document number: 112025020675

Country of ref document: BR

WWE Wipo information: entry into national phase

Ref document number: 2024716166

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2024716166

Country of ref document: EP

Effective date: 20251031

ENP Entry into the national phase

Ref document number: 2024716166

Country of ref document: EP

Effective date: 20251031

ENP Entry into the national phase

Ref document number: 2024716166

Country of ref document: EP

Effective date: 20251031

ENP Entry into the national phase

Ref document number: 2024716166

Country of ref document: EP

Effective date: 20251031

ENP Entry into the national phase

Ref document number: 2024716166

Country of ref document: EP

Effective date: 20251031